Kingie,
It would be easy to put up some positive 'rhetoric' - as Yokka always loved having me on about - but what's the point? I've done my dash with the fairies and my apparently casual attitude to the current situation - which I am not - just that like Boris I am resigned to whatever the outcome happens to be. Why? Because it is entirely out of my hands. It'[s quite liberating in a bizarre way.
Once upon a time I used to believe that the market was more or less a level playing field. Sure, the big boys played to a different set of rules, but there were always enough crumbs of opportunity for us retail 'investors' to feed off and make a living. If not a living, then at least enough to enable us to build a portfolio of some worth and plan for whatever - in my case lose the mortgage, pay for my daughter's education, and look forward to some kind of retirement - with a degree of confidence that it would, in time, happen the way we planned.
I also used to believe that I had some kind of insight into the macro healthcare industry, gleaned through countless hours of research, where Unilife was positioned in that industry, and how it would eventually play out.
That is no longer the case. Right now we are being given an object lesson - abject? - in what might fairly be described as a power-play by the big end of town who do not give a rats about what happens to the small end, or what we think, least of all how it effects our lives.
We all know what we've got by way of existing supply agreements potentially worth hundreds if not billions of dollars over the terms of the agreements, an emerging transition from R&D to reasonably significant commercial sales with scheduled production ramp from January next year for prefills, including - but not limited to - significantly increased demand from at least one existing customer for Finesse - Sanofi? - with Hikma also coming on-line, wearables progressively kicking in, human trials for various other devices, interest across the entire portfolio of platform technologies with at least twelve deals currently under negotiation, a significant Intellectual Property portfolio which is arguably the envy of the industry, and at least one additional major supply agreement in the wings waiting to hit.
Indeed, we are shareholders in a company, which, properly funded, could and will in my opinion go on to achieve wonderful things and prosper in the way we have all believed would one day happen. Unilife still has all the ingredients for a great company. In that respect nothing has changed.
In the meantime, we have various predatory funds desperately hungry for whatever stock they can lay their hands on by fair means or foul, existing global institutional shareholders continuing to add to their positions and new institutions coming onto a register burdened by one of the largest short positions of any company on the Naz, all the while a share price in freefall that has no apparent floor underneath to support it either technically or fundamentally, not helped by a complete cone of silence - understandable in my opinion - concerning the status of the MS review. You could be forgiven for thinking these professional positions are diametrically opposed to each other in terms of potential/desired outcomes. They are not.
In short, we know what we know, and we know what we don't know. It is the latter dearth of knowledge that is killing us. Well, me anyway. I cannot speculate any more. I cannot think of anything sensible to say. I am unable to provide any insight into what the future holds. I certainly find myself unable make any worthwhile contribution to this forum which has been a major part of my life for more years than I care to think about. When I try, people tell me to shut up.
So all I can do is sit this out. The alternative is to exit with a life-changing debt - not what I envisaged all those years ago when my wife - formerly a nurse, then a flight attendant - came home from a trip to Perth with a Shares magazine and an article about this emerging medical devices company called Unitract that had some brilliant technology for a retractable safety syringe.
What more can I say?
I personally believe we are on the cusp of a new - albeit excruciatingly painful - beginning.
But that's just me, optimistic to the end.
Oh, and I still believe in Santa
